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Empty follicle syndrome (EFS) is a condition in which no oocytes are obtained after an apparently successful ovarian stimulation.
Genuine EFS (GEFS) is diﬀerentiated from false EFS by an optimal level of human chorionic gonadotropin on the day of oocyte
retrieval. Some believe that GEFS does not exist and that it is only a reﬂection of the margin of error attendant upon the procedure
of oocyte aspiration. Others believe that GEFS is caused by dysfunctional folliculogenesis, resulting in early atresia of oocytes. In
this report, we present a case of apparent GEFS, in which immature oocytes were identiﬁed after ﬁltration of follicular aspirates.
Our ﬁndings suggest that delayed maturation of oocyte cumulus complexes in response to HCG might be an etiologic mechanism
in some cases of GEFS. This creates a situation similar to the aspiration of immature follicles, where germinal vesicle-stage oocytes
with dense scanty cumulus cells are often diﬃcult to identify under a dissecting microscope.
1.Introduction
Empty follicle syndrome (EFS) is a condition in which no
oocytes are retrieved after an apparently successful ovarian
stimulation [1, 2]. Its incidence has been estimated to be
around 0.2%–7% [1, 3–6]. This situation is frustrating and
highly stressful to both patients and the IVF team.
Empty follicle syndrome (EFS) was ﬁrst described by
Coulam et al. [7] in 4 patients with unexplained infertility,
who underwent 5 cycles of in vitro fertilization. They
suggested that EFS might represent a so far unknown cause
of infertility. In subsequent studies, EFS was reported in
couples with practically any causes of infertility [1, 2]. For
simplicity, Stevenson and Lashen [1] classiﬁed EFS into
genuine and false EFS. False EFS was deﬁned as a failure to
retrieve oocytes in the presence of low β-HCG level. Possible
etiologies include inappropriate administration of HCG [5,
8], defects in the biological preparations of HCG [6], or
individual variation in the bioavailability and metabolism of
HCG [2]. Genuine EFS was deﬁned as unsuccessful oocyte
retrievalafterapparentlynormal folliculardevelopment with
optimal β-HCG levels on the day of oocyte retrieval [1].
Some believed that genuine EFS was due solely to technical
diﬃculties during oocyte aspiration [9, 10]. Given the oocyte
aspiration retrieval rate of only 80%, despite the use of
follicular ﬂushing, van Heusden et al. [9] calculated the
chance of failure to recover at least one oocyte in their 14
EFS cases to be 0.064%–4%. This number was coincidentally
close to the reported prevalence of EFS in general and was
used as one argument against the existence of EFS as a
clinical entity. Ben-Shlomo et al. [4] reviewed 26 patients
with EFS and found no diﬀerences between successful and
unsuccessful cycles with respect to stimulation protocols,
hormonal response pattern or the number of large follicles
(≥15mm) detected by sonography. Ten of their patients
had been pregnant in the past and twenty had at least
one other IVF cycle that yielded oocytes. The authors,
therefore, concluded that failure to retrieve oocytes should
be regarded as a “sporadic event” rather than a syndrome.
They also noted that 4 of these patients had a history
of poor response to ovarian stimulation, implying that
perhaps ovarian dysfunction could play a role. Others [6,
11] also suggested dysfunctional folliculogenesis, a clinical
dysfunction in which abnormal granulosa cell function leads2 Case Reports in Medicine
to altered oocyte growth and early atresia, as the likely cause
of GEFS. Zreik et al. [12] found that patients with one GEFS
cyclehada20%riskofrecurrenceinlaterIVFcycles.Therisk
of recurrence increased with age. Those between 35–39 years
of age had a recurrence risk of 24%, increasing to 57% for
those >40 years old. They suggested ovarian aging, possibly
through altered granulosa cell function and apoptosis, might
be involved in the etiology of EFS, and especially in its
recurrence. Onalan et al. [13] described recurrent GEFS in
3 stimulated cycles in 2 sisters with congenital hearing loss
and postulated an inherited genetic factor as its etiology.
However,furtherreportedcasesandmoredetailedmolecular
investigations are necessary to verify this claim.
In this report, we present a case of apparent genuine
EFS. The interesting ﬁnding was that the follicular aspirates,
which contained no oocytes by conventional observation,
were found to harbor immature (germinal vesicle) oocytes
upon ﬁltration through a cell strainer.
2.CaseReport
A 32-year-old Thai woman was referred to us for in vitro
fertilization (IVF) treatment in June, 2008. Previous history
revealed that she had been treated for her unexplained infer-
tility at a provincial hospital in 2005. She was pregnant after
timing of sexual intercourse on her third cycle of clomiphene
citrate. Unfortunately, the pregnancy ended in a complete
spontaneous miscarriage at a gestational age of 5 weeks and
3 days. After the abortion, she tried to conceive on her
own without success. She went back to her previous doctor,
who treated her with 3 cycles of clomiphene, with timing of
sexualintercourse,followedby2cyclesofsuperovulationand
intrauterine insemination (IUI). After unsuccessful treat-
ments, the patient had diagnostic laparoscopy performed in
2006. Minimal pelvic endometriosis was found and visible
implants were cauterized. Dye injection revealed patency of
both fallopian tubes. She was treated with leuprorelin acetate
3.75mg (Enantone; Takeda, Osaka, Japan) monthly for 6
months, followed by another 2 cycles of superovulation and
IUI, to no avail.
A long luteal protocol was used for her IVF. She was
given 1.88mg of leuprorelin acetate (Enantone) on June
30th, 2008. Blood was taken to conﬁrm down—regulation
on July 9th, 2008 (cycle day 3), and recombinant follicle
stimulating hormone (rFSH—Puregon; Organon, Oss, the
Netherlands) 150IU per day was started. After three doses
of rFSH 150IU daily, blood was again taken and revealed an
estradiollevelof86.9pg/mL.ThedoseofrFSHwasincreased
t o2 0 0I Up e rd a yf o ra n o t h e rt w od a y sa n dr e p e a t e db l o o d
test revealed satisfactory rise of estradiol level. Transvaginal
ultrasound was performed 8 days later, revealing 12 follicles
as follows: 2×15mm, 1×14mm, 8×13mm and 1×12mm
follicles. Ultrasound was repeated 2 days later, revealing
2 × 19, 1 × 18, 4 × 17, 4 × 15 and 1 × 13mm follicles.
Human chorionic gonadotropin (HCG; Pregnyl, Organon)
10,000IU was administered intramuscularly and oocyte
pick-up was performed 36 hours later. At oocyte retrieval,
there was minimal ﬂuid in the cul-de-sac. All 12 follicles
were aspirated using a 16G double-lumen aspiration needle
(catalog no. K-OPSD-1635-A-L; Cook Medical, Brisbane,
Australia). Flushing was performed twice after each follicular
aspiration, using heparinized Dublecco’sphosphate-buﬀered
saline (DPBS; Gibco, BRL, NY, USA). Follicular and ﬂushing
ﬂuid from consecutive follicles were aspirated collectively
into warm 50-mL culture ﬂasks (Nunc, Roskilde, Denmark).
In our setting, two embryologists worked side by side,
routinely checking follicular aspirates previously examined
by the other. As no oocyte was obtained, we examined the
aspirates a third time, before a tentative diagnosis of “empty
follicle syndrome” was made.
The patient conﬁrmed that she had HCG injected by a
qualiﬁed nurse at the correct time, approximately 36 hours
before oocyte retrieval. Blood was immediately taken for
hormonal study. Her β-HCG level was found to be 851IU/L,
FSH 12IU/L, LH < 0.1IU/L, estradiol 2,637pg/mL and
progesterone 37.5ng/mL. Out of frustration, we decided
to have a closer look at the aspirates by ﬁltering them
through a 70-μm cell strainer (BD Falcon, Bedford, MA,
USA). Unfortunately, half of the follicular aspirates had
already been discarded by this time. To our great surprise, 4
immature (germinal vesicle-stage) oocytes were identiﬁed in
the remaining ﬂuid. Two oocytes had a very scant amount of
tightly-packed cumulus cells and the other two were nearly
cumulus-free, making it diﬃcult or impossible to identify
them without the aid of a cell strainer. As the oocytes
had been left standing at room temperature for too long
(>3 hours), we decided to discard them. The patient was
counseled regarding EFS. She was advised that the chance of
a recurrence in her case was negligible, and we would do our
best in her next cycle.
The patient came back for a second IVF attempt
4 months after the incident. Human menopausal
gonadotrophin (HMG; Menogon; Ferring GmbH, Kiel,
Germany) 225IU per day was started on cycle day 3 for 9
consecutive days. Ganirelix 0.25mg (Orgalutran; Organon)
was given daily on cycle days 8–11. HCG 10,000IU (Pregnyl,
Organon) was given on cycle day 12 and oocyte retrieval
was done 36 hours later (on cycle day 14). Twelve oocytes
were obtained and 9 embryos were produced by IVF. Two
embryos were transferred and 7 embryos were cryopreserved
by ultra-rapid freezing technique. Urine pregnancy test was
positive two weeks after the embryo transfer. Transvaginal
ultrasoundexaminationwasperformedsevenweeksafterthe
embryo transfer. A single gestational sac, with yolk sac and
fetal heart activity, was visualized inside the uterine cavity.
At the time of this report, the pregnancy was still ongoing.
3. Discussion
Premature LH surge was an unlikely explanation for GEFS in
our case as a single half dose of leuprolide depot was used in
a long down-regulation protocol to prevent its occurrence.
In a recent randomized study, Isikoglu et al. [14] showed
that a single half-dose of leuprolide depot was as eﬀective as
the multi-dose protocol for pituitary desensitization. In their
study [14], premature LH surge did not occur in any of theCase Reports in Medicine 3
51 cases who received this medication. The presence of intact
follicles at the time of oocyte retrieval also provided further
evidence against the occurrence of premature LH surge in
our case.
The usual retrieval rate of oocyte aspiration is 80% [9].
T h em a t h e m a t i c a lc h a n c ef o rf a i l u r et or e c o v e ra n yo o c y t ei n
our case, with 12 follicles, would be only 4 out of 10 million.
Such an extreme probability suggested that the margin of
error inherent in the procedure of oocyte aspiration itself
would be an unlikely explanation for EFS in our reported
case.
Initially,thepatientrespondedpoorlytoovarianstimula-
tion,makingitnecessarytoincreasethedosesofrFSH.Itwas
possible that abnormal folliculogenesis could have occurred
at the beginning of the cycle, as in other reported cases of
GEFS [4, 6]. Normal levels of estradiol and progesterone on
the day of oocyte retrieval, however, did not support the
contention by some authors [6, 11] that GEFS, at least in
our case, was due to early atresia of the oocytes. Abnormal
folliculogeneis could possibly modify the follicular response
toanovulatorydoseofHCG.Interestingly,MeniruandCraft
[15] suggested that there could be a delayed detachment
of oocyte-cumulus complex (OCC) from the follicular wall
following HCG injection. In their report, the ﬁrst dose
of HCG raised the plasma level of progesterone, but no
oocyteswereretrievedfromtheaspirationofoneovary.They
repeated HCG injection and were able to obtain 20 oocytes
from the other ovary at a second retrieval 24 hours later.
Hassan et al. [16] also reported similar ﬁndings, suggesting
that some patients might need a longer exposure time to
HCG in order for their OCCs to detach from the follicle
wall. In a similar way to our case, HCG could induce normal
progesterone production, but the ﬁnal maturation of the
OCCs was somehow delayed. As immature oocytes were
not free-ﬂoating in the follicular ﬂuid at the time of oocyte
retrieval, the yield of follicular aspiration, even with repeated
ﬂushing of the follicles, would be markedly reduced. We
postulated that the presence of fewer OCCs in the follicular
aspirates, together with the unique features of immature
OCCs, made it diﬃcult for the average embryologist to
identify them. Given the normal level of progesterone, we
questioned the role of a second HCG injection as suggested
by some authors [15, 16]. Perhaps oocyte maturation in
response to the ﬁrst dose of HCG just required more time
than 36 hours and mature oocytes could be aspirated later
on, regardless of the second HCG injection.
Recently, our center began to explore the use of in
vitro maturation (IVM) of oocytes from unstimulated cycles
in patients with polycystic ovary syndrome (PCOS). The
follicular aspirates from IVM cases were more heavily
contaminated with blood but they were, to a certain extent,
similar to that seen in this patient. Although we found only
4GV oocytes, it was possible that more immature oocytes
might have been missed in the remaining aspirate that was
discarded. Our PubMed search from 1986 to 2009, using
the keywords “empty follicle syndrome” or “failed oocyte
retrieval, ” revealed one case report [17] that also found
1 zona-free germinal vesicle-stage oocyte in the follicular
aspirate of 1 GEFS case.
In conclusion, some cases of genuine EFS might be
caused by a delayed maturation of OCCs in response to
HCG. The situation was similar to oocyte retrieval from
immature follicles. The lower number of immature oocytes
in the aspirates and the diﬃculty in identifying them could
lead to a mistaken diagnosis of GEFS.
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